Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
startups
2
×
acetylon pharmaceuticals
ambys medicines
biotech
boston blog main
boston top stories
cell therapy
constellation pharmaceuticals
deals
europe
fundings & exits
gene therapy
genentech
holger willenbring
ipo
jeffrey tong
juan carlos izpisua belmonte
keith dionne
life sciences
liver disease
markus grompe
martin burke
national blog main
national top stories
new york blog main
new york top stories
oregon stem cell center
proteon therapeutics
salk institute for biological studies
san diego blog main
san diego top stories
san francisco
san francisco blog main
san francisco top stories
takeda
tc
third rock ventures
ucsf
university of illinois urbana-champaign
vc
What
big
2
×
new
2
×
startup
additional
advances
aiming
ambys
based
bios
biotech
cambridge
canada
chronic
combines
company
conditions
control
data
deadly
deal
debuted
develop
developing
diseases
engineering
formed
funding
future
hardware
interface
launch
liver
make
medical
medicines
million
montreal
neural
newly
office
Language
Current search:
big
×
new
×
startups
×
@techcrunch.com
5 years ago
Bios raises $4.5M to further develop its ‘neural interface’ and new ways to treat chronic medical conditions
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?